Search results
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC Universal via AOL· 2 days agoBy attaching a chemotherapy drug to an antibody, doctors are able to deliver more potent...
Scaling back cancer treatment can help some patients without compromising outcomes, studies find
Euronews via Yahoo News· 1 day agoHalf received a common treatment plan that included chemotherapy and surgery on the oesophagus, the...
Chemotherapy type can be personalized to decrease | Newswise
Newswise· 1 day agoTaxane-based chemotherapies are the primary curative therapy for breast cancer, but they can lead to...
Cancer patients often do better with less intensive treatment, research shows
NBC NEWS· 1 day agoScaling back treatment for three kinds of cancer can make life easier for patients without...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 1 day agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...
New Gene Tests Can Predict if a Drug Will Work for a Patient
Medscape· 4 days ago"About 9 out of 10 people will have a genetic difference in their DNA that can impact how they...
With new Enhertu data, an ADC could overtake chemo in breast cancer
BioPharma Dive via Yahoo Finance· 2 days agoWhile this side effect wasn’t serious for most patients who received Enhertu, about 5% stopped...
... Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of...
Valley City Times Record· 2 days agoCarried out under the company's collaborative model, this Investigator-Initiated Trial (IIT)...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters via Yahoo News· 4 days agoTrodelvy has accelerated U.S. approval for treating advanced urothelial cancer, but Gilead on...
GSK builds case for return of multiple myeloma drug Blenrep
BioPharma Dive via Yahoo Finance· 2 days agoStudy results showed the antibody-drug conjugate helped stave off disease progression better than a...